ROIV
Roivant Sciences Ltd
35.70$
+0.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
Roivant Sciences Ltd (ROIV) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -263 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -85 | -111 | -98 | -237 | -106 | -141 | -121 | -268 | -147 | -252 | -190 | -223 | -179 | -250 | -196 | -210 | -108 | -267 | -267 | -207 | -173 | -204 | -186 | -196 | -164 | -263 | -809 | |
| – | – | – | – | – | – | 0.7 | 0.7 | 0.7 | 2.7 | 7.8 | 5.2 | 6.0 | 5.8 | 7.3 | 5.4 | 2.0 | 4.8 | 4.8 | 2.9 | 1.4 | 1.1 | 0.9 | -8.0 | 30 | 0.6 | 24 | |
| – | 14 | 14 | 17 | 39 | 19 | 397 | 71 | 77 | 73 | 62 | 58 | 25 | 49 | 49 | 54 | 47 | 72 | 72 | 84 | 83 | 82 | 82 | 105 | 77 | 83 | 347 | |
| 12 | -94 | -61 | – | 297 | -47 | 3.4 | 168 | 74 | 109 | 97 | 90 | -20 | 51 | 90 | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -14 | 0.3 | -21 | 107 | -12 | 92 | -102 | 38 | -48 | 31 | 2.7 | 21 | -35 | 17 | 21 | 16 | 10 | 10 | -53 | 34 | -37 | 7.1 | 9.4 | -601 | 7.1 | -578 | |
| 1.8 | 0.3 | 1.3 | 0.1 | 4.1 | 2.3 | 2.8 | 6.1 | 6.3 | 7.5 | 3.1 | 0.5 | 1.6 | 0.4 | 0.3 | 0.4 | 0.3 | 1.0 | 1.0 | 1.8 | 0.8 | 4.0 | 7.8 | 4.9 | 1.3 | 0.4 | 14 | |
| -48 | -26 | -1.9 | – | -4.1 | -2.3 | 317 | -6.1 | -5.7 | -7.5 | -147 | -3.5 | 114 | 0.1 | -36 | 5,233 | 6.9 | -3,294 | -3,294 | 454 | 1,074 | -1,086 | 120 | 149 | 134 | 281 | 685 | |
| – | – | – | – | – | – | – | – | – | – | – | 1.1 | 0.3 | 6.0 | 6.0 | – | 6.0 | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -8.3 | – | -1.1 | 0.3 | 21 | -216 | 0.0 | 222 | -106 | -106 | -243 | -295 | -208 | 0.0 | 0.0 | -111 | -207 | -318 | |
| 15 | 15 | 15 | – | 15 | 15 | 153 | 153 | 153 | 153 | -7.3 | -7.4 | -8.0 | -7.6 | -7.6 | – | – | – | -1.8 | -49 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | |
| -1,100 | 181 | 176 | 0.5 | 99 | 10 | 304 | -8.4 | 1.1 | 142 | -7.3 | 154 | 210 | 7.5 | 208 | 237 | -33 | -109 | -109 | -273 | -177 | -188 | 63 | 289 | -30 | -388 | -66 | |
| -1,233 | 44 | 76 | -237 | -11 | -133 | 501 | -283 | -152 | -118 | -344 | -72 | 151 | -242 | -26 | 5,262 | -178 | -3,664 | -3,664 | -27 | 724 | -1,477 | -1.4 | 242 | -58 | -370 | -188 | |
| – | -111 | -99 | -237 | -110 | -144 | -123 | -275 | -154 | -260 | -193 | -223 | -181 | -250 | -197 | -211 | -109 | -268 | -268 | -209 | -173 | -208 | -194 | -192 | -165 | -264 | -814 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.